The prevalence of mutations affecting these Rad51 paralogs in our cohort was comparable to a prior study of ovarian cancer patients which identified a similar overall prevalence of loss-of-function germline variants in RAD51B/C/D (combined 22/3112 cases)16. This evidence concerns the gene RAD51 and ovarian carcinoma.